首页 > 最新文献

Journal of Otolaryngology - Head & Neck Surgery最新文献

英文 中文
Correction: The timing of drain removal in parotidectomies: outcomes of removal at 4 h post-operatively and a Canadian survey of practice patterns. 更正:腮腺切除术中引流管移除的时间:术后4小时移除的结果和加拿大对实践模式的调查。
IF 3.4 3区 医学 Q1 OTORHINOLARYNGOLOGY Pub Date : 2023-10-26 DOI: 10.1186/s40463-023-00678-x
Alice Q Liu, Oleksandr Butskiy, Veronique Wan Fook Cheung, Donald W Anderson
{"title":"Correction: The timing of drain removal in parotidectomies: outcomes of removal at 4 h post-operatively and a Canadian survey of practice patterns.","authors":"Alice Q Liu, Oleksandr Butskiy, Veronique Wan Fook Cheung, Donald W Anderson","doi":"10.1186/s40463-023-00678-x","DOIUrl":"10.1186/s40463-023-00678-x","url":null,"abstract":"","PeriodicalId":16615,"journal":{"name":"Journal of Otolaryngology - Head & Neck Surgery","volume":"52 1","pages":"70"},"PeriodicalIF":3.4,"publicationDate":"2023-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605190/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54229574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A novel intraoperative continuous monitoring method combining dorsal cochlear nucleus action potentials monitoring with auditory nerve test system. 一种将耳蜗背核动作电位监测与听神经测试系统相结合的术中连续监测新方法。
IF 3.4 3区 医学 Q1 OTORHINOLARYNGOLOGY Pub Date : 2023-10-06 DOI: 10.1186/s40463-023-00671-4
Makoto Hosoya, Yuriko Nagaoka, Takeshi Wakabayashi, Marie N Shimanuki, Takanori Nishiyama, Masafumi Ueno, Hiroyuki Ozawa, Naoki Oishi

Highly accurate real-time cochlear nerve monitoring to preserve cochlear nerve function is essential for simultaneous cochlear implantation and ipsilateral vestibular schwannoma resection. In the present study, we developed a novel real-time monitoring system that combines dorsal cochlear nucleus action potential monitoring with intracochlear stimulating electrodes (Auditory Nerve Test System, ANTS). We used this system for a case with vestibular schwannoma resection via the translabyrinthine approach. The monitoring system developed in this study detected highly reliable evoked potentials from the cochlear nerve every two seconds continuously during tumor resection. Near-total tumor resection was achieved, and cochlear implantation was performed successfully after confirming the preservation of cochlear nerve function in a case. The patient's hearing was well compensated by cochlear implantation after surgery. Our novel method continuously achieved real-time monitoring of the cochlear nerve every two seconds during vestibular schwannoma resection. The usefulness of this monitoring system for simultaneous tumor resection and cochlear implantation was demonstrated in the present case. The system developed in this study is compatible with continuous facial nerve monitoring. This highly accurate and novel monitoring method will broaden the number of candidates for this type of surgery in the future.

高度准确的实时耳蜗神经监测以保持耳蜗神经功能对于同时进行耳蜗植入和同侧前庭神经鞘瘤切除至关重要。在本研究中,我们开发了一种新的实时监测系统,该系统将耳蜗背核动作电位监测与耳蜗内刺激电极相结合(听觉神经测试系统,ANTS)。我们将该系统用于一例经迷路入路前庭神经鞘瘤切除术。本研究中开发的监测系统在肿瘤切除过程中连续每两秒检测一次来自耳蜗神经的高度可靠的诱发电位。在确认一例患者的耳蜗神经功能得到保留后,实现了近全肿瘤切除,并成功进行了人工耳蜗植入。手术后植入人工耳蜗,病人的听力得到了很好的补偿。我们的新方法在前庭神经鞘瘤切除过程中连续实现了每两秒对耳蜗神经的实时监测。该监测系统在同时进行肿瘤切除和耳蜗植入方面的实用性在本例中得到了证明。本研究开发的系统与面部神经连续监测兼容。这种高度准确和新颖的监测方法将在未来扩大这类手术的候选人数。
{"title":"A novel intraoperative continuous monitoring method combining dorsal cochlear nucleus action potentials monitoring with auditory nerve test system.","authors":"Makoto Hosoya, Yuriko Nagaoka, Takeshi Wakabayashi, Marie N Shimanuki, Takanori Nishiyama, Masafumi Ueno, Hiroyuki Ozawa, Naoki Oishi","doi":"10.1186/s40463-023-00671-4","DOIUrl":"10.1186/s40463-023-00671-4","url":null,"abstract":"<p><p>Highly accurate real-time cochlear nerve monitoring to preserve cochlear nerve function is essential for simultaneous cochlear implantation and ipsilateral vestibular schwannoma resection. In the present study, we developed a novel real-time monitoring system that combines dorsal cochlear nucleus action potential monitoring with intracochlear stimulating electrodes (Auditory Nerve Test System, ANTS). We used this system for a case with vestibular schwannoma resection via the translabyrinthine approach. The monitoring system developed in this study detected highly reliable evoked potentials from the cochlear nerve every two seconds continuously during tumor resection. Near-total tumor resection was achieved, and cochlear implantation was performed successfully after confirming the preservation of cochlear nerve function in a case. The patient's hearing was well compensated by cochlear implantation after surgery. Our novel method continuously achieved real-time monitoring of the cochlear nerve every two seconds during vestibular schwannoma resection. The usefulness of this monitoring system for simultaneous tumor resection and cochlear implantation was demonstrated in the present case. The system developed in this study is compatible with continuous facial nerve monitoring. This highly accurate and novel monitoring method will broaden the number of candidates for this type of surgery in the future.</p>","PeriodicalId":16615,"journal":{"name":"Journal of Otolaryngology - Head & Neck Surgery","volume":"52 1","pages":"67"},"PeriodicalIF":3.4,"publicationDate":"2023-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557301/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41099394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Variability and accuracy of multiple saliva pepsin measurements in laryngopharyngeal reflux patients. 咽返流患者唾液胃蛋白酶多项测定的变异性和准确性。
IF 3.4 3区 医学 Q1 OTORHINOLARYNGOLOGY Pub Date : 2023-10-04 DOI: 10.1186/s40463-023-00670-5
Jerome R Lechien, Francois Bobin

Objective: To study the variability and diagnostic value of multiple salivary pepsin measurements in the detection of laryngopharyngeal reflux (LPR).

Methods: Patients with LPR symptoms were consecutively recruited from December 2019 to Augustus 2022. Twenty-one asymptomatic individuals completed the study. The diagnostic was confirmed with hypopharyngeal-esophageal impedance-pH monitoring (HEMII-pH). Patients collected three saliva samples during the 24-h testing period. Symptoms and findings were studied with reflux symptom score-12 and reflux sign assessment. Sensitivity, specificity, positive (PPV) and negative (NPV) predictive values of pepsin measurements were calculated considering morning, post-lunch and post-dinner samples. The consistency and relationship between HEMII-pH, pepsin measurements, and clinical features were investigated.

Results: Morning, post-lunch and post-dinner saliva pepsin concentrations were measured in 42 patients. Pepsin measurements were 64.9%, 59.5%, and 59.0% sensitive for morning, post-lunch and post-dinner collections at cutoff ≥ 16 ng/mL. Considering the highest concentration of the three pepsin saliva collections, the accuracy, sensitivity, specificity and PPV were 70.5%, 73.0%; 66.7% and 78.9%, respectively. Morning pepsin measurements reported higher consistency, sensitivity, and specificity than post-dinner and post-lunch pepsin measurements.

Conclusion: The collection of several saliva pepsin samples improves the detection rate of LPR. In case of high clinical LPR suspicion and negative pepsin test, a HEMII-pH study could provide further diagnostic information.

目的:研究多种唾液胃蛋白酶测定在检测喉咽反流(LPR)中的变异性和诊断价值。方法:从2019年12月至2022年8月连续招募有LPR症状的患者。21名无症状个体完成了这项研究。下咽食管阻抗pH监测(HEMII pH)证实了诊断。患者在24小时的测试期间采集了三份唾液样本。采用反流症状评分-12和反流症状评估对症状和结果进行研究。考虑早晨、午餐后和晚餐后的样本,计算胃蛋白酶测量的敏感性、特异性、阳性(PPV)和阴性(NPV)预测值。研究了HEMII pH值、胃蛋白酶测定值和临床特征之间的一致性及其关系。结果:测定了42例患者早晨、午餐后和晚餐后唾液胃蛋白酶的浓度。截止时,胃蛋白酶测量对早晨、午餐后和晚餐后的采集敏感度分别为64.9%、59.5%和59.0% ≥ 16 ng/mL。考虑到三种胃蛋白酶唾液采集的最高浓度,准确性、敏感性、特异性和PPV分别为70.5%、73.0%;分别为66.7%和78.9%。晨间胃蛋白酶测定报告的一致性、敏感性和特异性高于餐后和午餐后胃蛋白酶测定。结论:采集唾液胃蛋白酶样品可提高LPR的检出率。在临床怀疑LPR高且胃蛋白酶检测呈阴性的情况下,HEMII pH研究可以提供进一步的诊断信息。
{"title":"Variability and accuracy of multiple saliva pepsin measurements in laryngopharyngeal reflux patients.","authors":"Jerome R Lechien, Francois Bobin","doi":"10.1186/s40463-023-00670-5","DOIUrl":"10.1186/s40463-023-00670-5","url":null,"abstract":"<p><strong>Objective: </strong>To study the variability and diagnostic value of multiple salivary pepsin measurements in the detection of laryngopharyngeal reflux (LPR).</p><p><strong>Methods: </strong>Patients with LPR symptoms were consecutively recruited from December 2019 to Augustus 2022. Twenty-one asymptomatic individuals completed the study. The diagnostic was confirmed with hypopharyngeal-esophageal impedance-pH monitoring (HEMII-pH). Patients collected three saliva samples during the 24-h testing period. Symptoms and findings were studied with reflux symptom score-12 and reflux sign assessment. Sensitivity, specificity, positive (PPV) and negative (NPV) predictive values of pepsin measurements were calculated considering morning, post-lunch and post-dinner samples. The consistency and relationship between HEMII-pH, pepsin measurements, and clinical features were investigated.</p><p><strong>Results: </strong>Morning, post-lunch and post-dinner saliva pepsin concentrations were measured in 42 patients. Pepsin measurements were 64.9%, 59.5%, and 59.0% sensitive for morning, post-lunch and post-dinner collections at cutoff ≥ 16 ng/mL. Considering the highest concentration of the three pepsin saliva collections, the accuracy, sensitivity, specificity and PPV were 70.5%, 73.0%; 66.7% and 78.9%, respectively. Morning pepsin measurements reported higher consistency, sensitivity, and specificity than post-dinner and post-lunch pepsin measurements.</p><p><strong>Conclusion: </strong>The collection of several saliva pepsin samples improves the detection rate of LPR. In case of high clinical LPR suspicion and negative pepsin test, a HEMII-pH study could provide further diagnostic information.</p>","PeriodicalId":16615,"journal":{"name":"Journal of Otolaryngology - Head & Neck Surgery","volume":"52 1","pages":"66"},"PeriodicalIF":3.4,"publicationDate":"2023-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548621/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41117066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Functional outcome following intracapsular resection of head and neck peripheral nerve sheath tumors: a retrospective cohort. 头颈部周围神经鞘肿瘤囊内切除术后的功能结果:一项回顾性队列研究。
IF 3.4 3区 医学 Q1 OTORHINOLARYNGOLOGY Pub Date : 2023-10-03 DOI: 10.1186/s40463-023-00646-5
Liyona Kampel, Marga Serafimova, Shaun Edalati, Adi Brenner, Razan Masarwy, Anton Warshavsky, Gilad Horowitz, Yuval Shapira, Nidal Muhanna

Background: Intracapsular resection of head and neck peripheral nerve sheath tumors (PNST) has emerged as a nerve-preserving technique compared to en bloc resection. The aim of this study was to evaluate and compare the functional outcome of both surgical techniques performed at a single tertiary referral center.

Methods: This is a retrospective cohort of patients with head and neck PNST undergoing surgical resection from 2011 to 2021 at the Tel Aviv Sourasky Medical Center. Demographic data, the nerve of origin and surgical technique, including the use of intraoperative nerve monitoring were recorded and analyzed in association with postoperative functional outcomes.

Results: Overall, 25 patients who had a cervical or parapharyngeal PNST resected were included. Nerve function was preserved in 11 of 18 patients (61%) who underwent intracapsular resection, while all those who underwent en bloc resections inevitably suffered from neurologic deficits (100%, N = 7). Sympathetic chain origin and an apparent neurologic deficit pre-operatively were associated with postoperative neural compromise.

Conclusion: Improved functional outcome can be anticipated following intracapsular resection of extracranial head and neck PNST compared to complete resection, particularly in asymptomatic patients.

背景:与整体切除术相比,头颈部周围神经鞘肿瘤的囊内切除术已成为一种神经保护技术。本研究的目的是评估和比较在单一三级转诊中心进行的两种手术技术的功能结果。方法:这是2011年至2021年在特拉维夫苏拉斯基医疗中心接受手术切除的头颈部PNST患者的回顾性队列。记录并分析人口统计学数据、起源神经和手术技术,包括术中神经监测的使用,以及术后功能结果。结果:总的来说,25名切除了颈部或咽旁PNST的患者被包括在内。在接受囊内切除的18名患者中,有11名(61%)的神经功能得到了保留,而所有接受整体切除的患者都不可避免地存在神经功能缺陷(100%,N = 7) 。术前交感神经链起源和明显的神经功能缺损与术后神经损害有关。结论:与完全切除相比,颅外头颈部PNST囊内切除术后的功能结果有望改善,尤其是在无症状患者中。
{"title":"Functional outcome following intracapsular resection of head and neck peripheral nerve sheath tumors: a retrospective cohort.","authors":"Liyona Kampel, Marga Serafimova, Shaun Edalati, Adi Brenner, Razan Masarwy, Anton Warshavsky, Gilad Horowitz, Yuval Shapira, Nidal Muhanna","doi":"10.1186/s40463-023-00646-5","DOIUrl":"10.1186/s40463-023-00646-5","url":null,"abstract":"<p><strong>Background: </strong>Intracapsular resection of head and neck peripheral nerve sheath tumors (PNST) has emerged as a nerve-preserving technique compared to en bloc resection. The aim of this study was to evaluate and compare the functional outcome of both surgical techniques performed at a single tertiary referral center.</p><p><strong>Methods: </strong>This is a retrospective cohort of patients with head and neck PNST undergoing surgical resection from 2011 to 2021 at the Tel Aviv Sourasky Medical Center. Demographic data, the nerve of origin and surgical technique, including the use of intraoperative nerve monitoring were recorded and analyzed in association with postoperative functional outcomes.</p><p><strong>Results: </strong>Overall, 25 patients who had a cervical or parapharyngeal PNST resected were included. Nerve function was preserved in 11 of 18 patients (61%) who underwent intracapsular resection, while all those who underwent en bloc resections inevitably suffered from neurologic deficits (100%, N = 7). Sympathetic chain origin and an apparent neurologic deficit pre-operatively were associated with postoperative neural compromise.</p><p><strong>Conclusion: </strong>Improved functional outcome can be anticipated following intracapsular resection of extracranial head and neck PNST compared to complete resection, particularly in asymptomatic patients.</p>","PeriodicalId":16615,"journal":{"name":"Journal of Otolaryngology - Head & Neck Surgery","volume":"52 1","pages":"65"},"PeriodicalIF":3.4,"publicationDate":"2023-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546627/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41141284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The argument against the use of dupilumab in patients with limited polyp burden in chronic rhinosinusitis with nasal polyposis (CRSwNP). 反对在慢性鼻窦炎伴鼻息肉病(CRSwNP)息肉负担有限的患者中使用杜匹单抗的论点。
IF 3.4 3区 医学 Q1 OTORHINOLARYNGOLOGY Pub Date : 2023-09-28 DOI: 10.1186/s40463-023-00668-z
Scott A Hardison, Brent A Senior

Dupilumab and other biologics have revolutionized the management of recalcitrant polyps in patients with chronic rhinosinusitis with nasal polyposis (CRSwNP). Despite strong evidence for the efficacy of dupilumab in treating polyps, factors such as cost and uncertain efficacy over surgery have limited its use to patients who have failed the use of topical nasal steroids and initial surgical management. Likewise, the use of this drug is often directed towards patients with greater polyp burdens. Recent studies, however, have investigated the use of dupilumab and other biologics in expanded patient populations, including those with limited polyp burden. The overall trend in the literature suggests a future move towards the use of biologics as first-line therapy for all patients with CRSwNP. The arguments against widespread, routine use of dupilumab and biologics in all patients with CRSwNP are threefold. First, endoscopic sinus surgery has been found to provide similar symptomatic benefit to dupilumab in the treatment of these patient populations. The surgical improvement of patients' sinonasal anatomy offers a rapid elimination of sources of ongoing inflammation that contribute to long-term polyp formation and symptoms. Medical non-compliance in this specific patient population is known to be an issue, with surgery offering a much greater long-term prospect of symptomatic relief in non-compliant patients. The second concern revolves around the potential for side effects of dupilumab and other biologics. Initial studies have shown an acceptable safety profile, but trials assessing the use of dupilumab for a separate indication revealed a higher rate of conjunctivitis. Long-term safety data is limited for biologics, and we must be prepared for the possibility of severe, unanticipated adverse events in the future. Our third and most profound concern is the significant cost of dupilumab. This medication is enormously expensive, and all current literature suggests that treatment would need to be life-long to remain effective. Studies comparing endoscopic sinus surgery to various biologics, including dupilumab, have shown comparable overall quality of life metrics with biologics, all while delivering considerably higher anticipated lifetime costs. As our knowledge progresses regarding the efficacy of dupilumab and other biologics in a variety of clinic situations, it is important to understand the context in which these advances are being made. While dupilumab and other biologics offer undeniable efficacy in the treatment of chronic rhinosinusitis with nasal polyposis which has failed to respond to standard therapies, we argue that biologics remain only a component of effective management in this patient population. Endoscopic sinus surgery and topical nasal steroids offer equal efficacy and substantially lower costs than biologics, and these factors should be considered when selecting treatment options for patients.

Dupilumab和其他生物制剂彻底改变了慢性鼻窦炎伴鼻息肉病(CRSwNP)患者顽固性息肉的治疗。尽管有强有力的证据表明dupilumab治疗息肉的疗效,但成本和手术疗效不确定等因素限制了其在未使用局部鼻类固醇和初次手术治疗的患者中的使用。同样,这种药物的使用通常针对息肉负担较大的患者。然而,最近的研究调查了杜匹单抗和其他生物制剂在扩大的患者群体中的使用,包括那些息肉负担有限的患者。文献中的总体趋势表明,未来将使用生物制剂作为所有CRSwNP患者的一线治疗。反对在所有CRSwNP患者中广泛、常规使用杜匹单抗和生物制剂的论点有三个。首先,已经发现鼻内镜鼻窦手术在治疗这些患者群体中提供了与dupilumab类似的症状益处。通过手术改善患者的鼻腔解剖结构,可以快速消除导致长期息肉形成和症状的持续炎症源。众所周知,这一特定患者群体的医疗不合规是一个问题,手术为不合规患者提供了更大的长期症状缓解前景。第二个问题围绕着杜匹单抗和其他生物制剂的潜在副作用。初步研究表明,其安全性是可以接受的,但评估使用杜匹单抗作为单独适应症的试验显示,结膜炎的发生率更高。生物制剂的长期安全性数据有限,我们必须为未来发生严重、意外不良事件的可能性做好准备。我们的第三个也是最深切的担忧是dupilumab的巨大成本。这种药物非常昂贵,目前所有的文献都表明,治疗需要终身才能保持有效。将鼻窦内窥镜手术与包括dupilumab在内的各种生物制品进行比较的研究表明,与生物制品相比,总体生活质量指标相当,同时预期寿命成本也高得多。随着我们对dupilumab和其他生物制剂在各种临床情况下的疗效的了解不断深入,了解这些进展的背景很重要。尽管dupilumab和其他生物制剂在治疗慢性鼻窦炎伴鼻息肉病方面具有不可否认的疗效,但我们认为,生物制剂仍然只是该患者群体有效管理的一个组成部分。鼻内窥镜鼻窦手术和局部鼻腔类固醇比生物制剂具有同等的疗效和显著更低的成本,在为患者选择治疗方案时应考虑这些因素。
{"title":"The argument against the use of dupilumab in patients with limited polyp burden in chronic rhinosinusitis with nasal polyposis (CRSwNP).","authors":"Scott A Hardison, Brent A Senior","doi":"10.1186/s40463-023-00668-z","DOIUrl":"10.1186/s40463-023-00668-z","url":null,"abstract":"<p><p>Dupilumab and other biologics have revolutionized the management of recalcitrant polyps in patients with chronic rhinosinusitis with nasal polyposis (CRSwNP). Despite strong evidence for the efficacy of dupilumab in treating polyps, factors such as cost and uncertain efficacy over surgery have limited its use to patients who have failed the use of topical nasal steroids and initial surgical management. Likewise, the use of this drug is often directed towards patients with greater polyp burdens. Recent studies, however, have investigated the use of dupilumab and other biologics in expanded patient populations, including those with limited polyp burden. The overall trend in the literature suggests a future move towards the use of biologics as first-line therapy for all patients with CRSwNP. The arguments against widespread, routine use of dupilumab and biologics in all patients with CRSwNP are threefold. First, endoscopic sinus surgery has been found to provide similar symptomatic benefit to dupilumab in the treatment of these patient populations. The surgical improvement of patients' sinonasal anatomy offers a rapid elimination of sources of ongoing inflammation that contribute to long-term polyp formation and symptoms. Medical non-compliance in this specific patient population is known to be an issue, with surgery offering a much greater long-term prospect of symptomatic relief in non-compliant patients. The second concern revolves around the potential for side effects of dupilumab and other biologics. Initial studies have shown an acceptable safety profile, but trials assessing the use of dupilumab for a separate indication revealed a higher rate of conjunctivitis. Long-term safety data is limited for biologics, and we must be prepared for the possibility of severe, unanticipated adverse events in the future. Our third and most profound concern is the significant cost of dupilumab. This medication is enormously expensive, and all current literature suggests that treatment would need to be life-long to remain effective. Studies comparing endoscopic sinus surgery to various biologics, including dupilumab, have shown comparable overall quality of life metrics with biologics, all while delivering considerably higher anticipated lifetime costs. As our knowledge progresses regarding the efficacy of dupilumab and other biologics in a variety of clinic situations, it is important to understand the context in which these advances are being made. While dupilumab and other biologics offer undeniable efficacy in the treatment of chronic rhinosinusitis with nasal polyposis which has failed to respond to standard therapies, we argue that biologics remain only a component of effective management in this patient population. Endoscopic sinus surgery and topical nasal steroids offer equal efficacy and substantially lower costs than biologics, and these factors should be considered when selecting treatment options for patients.</p>","PeriodicalId":16615,"journal":{"name":"Journal of Otolaryngology - Head & Neck Surgery","volume":"52 1","pages":"64"},"PeriodicalIF":3.4,"publicationDate":"2023-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537999/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41159051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reconsidering routine admission for children under age 3 undergoing partial tonsillectomy: a prospective study. 重新考虑接受部分扁桃体切除术的3岁以下儿童的常规入院:一项前瞻性研究。
IF 3.4 3区 医学 Q1 OTORHINOLARYNGOLOGY Pub Date : 2023-09-23 DOI: 10.1186/s40463-023-00659-0
Ameen Biadsee, Craig Nathanson, Or Dagan, Firas Kassem, Avishai Stahl, Tova Mishali, Yaniv Ebner, Brian Rotenberg

Background: Partial Tonsillectomy (PT) is an alternative method to treat sleep disordered breathing (SDB) and/or obstructive sleep apnea (OSA). The current guidelines do not differentiate it from traditional tonsillectomy. Thus, children younger than 3 years old undergoing PT are admitted for surveillance similar to traditional tonsillectomy due to possible postoperative complications. The aim of this study is to assess the risks of PT in children 3 years old and younger, compared to older children.

Methods: Children underwent inpatient partial tonsillectomy and/or adenoidectomy, due to SDB/OSA, from 2018 to 2020. A special protocol was designed, including follow-up at 2-, 4-, 6-, 8- and 24-h after surgery. Variables analyzed included visual analogue pain score, oral intake, oxygen saturation, pulse rate, postoperative hemorrhage, urine output, temperature, analgesics and fluid administration. Furthermore, major interventions were recorded. Comparison of all variables between children younger than 3 years old with older children was performed.

Results: Ninety-two children were included; mean age of the whole cohort was 44.5 ± 21.9 months. Thirty-five (38%) children were 3-years old or younger and n = 57 (62%) were older than 3 years old, with no significant statistical difference in sex (p = 0.22). Mean age in the younger group was 25.7 ± 6.9 months, and 56.1 ± 20.1 months in the older group. In total we had 7 children with post-operative complications; 4 with fever, 3 with low intake. There were no major interventions recorded in either group. The complications were more common in the older group (n = 5) than the younger group (n = 2) without a statistical significance (p = 0.59). There were no differences in VAS, use of painkillers, oral intake, urine output, oxygen saturation and tachycardia among the two groups.

Conclusion: This study supports that children undergoing ambulatory PT may be at low risk of complications, regardless of age.

背景:部分扁桃体切除术(PT)是治疗睡眠呼吸障碍(SDB)和/或阻塞性睡眠呼吸暂停(OSA)的一种替代方法。目前的指导方针并没有将其与传统的扁桃体切除术区分开来。因此,由于可能的术后并发症,接受PT的3岁以下儿童被允许接受类似于传统扁桃体切除术的监测。本研究的目的是评估3岁及以下儿童与年龄较大儿童相比患PT的风险。方法:2018年至2020年,儿童因SDB/OSA接受了住院部分扁桃体切除术和/或腺样体切除术。设计了一个特殊的方案,包括术后2、4、6、8和24小时的随访。分析的变量包括视觉模拟疼痛评分、口服量、血氧饱和度、脉搏率、术后出血、尿量、体温、止痛药和液体给药。此外,还记录了主要干预措施。对3岁以下儿童和年龄较大儿童的所有变量进行了比较。结果:包括92名儿童;整个队列的平均年龄为44.5岁 ± 21.9个月。35名(38%)儿童年龄在3岁或以下 = 年龄大于3岁者57例(62%),性别差异无统计学意义(p = 0.22)。年轻组的平均年龄为25.7岁 ± 6.9个月,56.1 ± 老年组20.1个月。我们总共有7名儿童出现术后并发症;发热4例,低摄入量3例。两组均未记录到重大干预措施。并发症在老年组中更为常见(n = 5) 比年轻组(n = 2) 无统计学意义(p = 0.59)。两组在VAS、止痛药的使用、口服量、尿量、血氧饱和度和心动过速方面没有差异。结论:本研究支持接受门诊PT的儿童无论年龄大小,并发症的风险都很低。
{"title":"Reconsidering routine admission for children under age 3 undergoing partial tonsillectomy: a prospective study.","authors":"Ameen Biadsee, Craig Nathanson, Or Dagan, Firas Kassem, Avishai Stahl, Tova Mishali, Yaniv Ebner, Brian Rotenberg","doi":"10.1186/s40463-023-00659-0","DOIUrl":"10.1186/s40463-023-00659-0","url":null,"abstract":"<p><strong>Background: </strong>Partial Tonsillectomy (PT) is an alternative method to treat sleep disordered breathing (SDB) and/or obstructive sleep apnea (OSA). The current guidelines do not differentiate it from traditional tonsillectomy. Thus, children younger than 3 years old undergoing PT are admitted for surveillance similar to traditional tonsillectomy due to possible postoperative complications. The aim of this study is to assess the risks of PT in children 3 years old and younger, compared to older children.</p><p><strong>Methods: </strong>Children underwent inpatient partial tonsillectomy and/or adenoidectomy, due to SDB/OSA, from 2018 to 2020. A special protocol was designed, including follow-up at 2-, 4-, 6-, 8- and 24-h after surgery. Variables analyzed included visual analogue pain score, oral intake, oxygen saturation, pulse rate, postoperative hemorrhage, urine output, temperature, analgesics and fluid administration. Furthermore, major interventions were recorded. Comparison of all variables between children younger than 3 years old with older children was performed.</p><p><strong>Results: </strong>Ninety-two children were included; mean age of the whole cohort was 44.5 ± 21.9 months. Thirty-five (38%) children were 3-years old or younger and n = 57 (62%) were older than 3 years old, with no significant statistical difference in sex (p = 0.22). Mean age in the younger group was 25.7 ± 6.9 months, and 56.1 ± 20.1 months in the older group. In total we had 7 children with post-operative complications; 4 with fever, 3 with low intake. There were no major interventions recorded in either group. The complications were more common in the older group (n = 5) than the younger group (n = 2) without a statistical significance (p = 0.59). There were no differences in VAS, use of painkillers, oral intake, urine output, oxygen saturation and tachycardia among the two groups.</p><p><strong>Conclusion: </strong>This study supports that children undergoing ambulatory PT may be at low risk of complications, regardless of age.</p>","PeriodicalId":16615,"journal":{"name":"Journal of Otolaryngology - Head & Neck Surgery","volume":"52 1","pages":"63"},"PeriodicalIF":3.4,"publicationDate":"2023-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517495/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41119939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The accuracy of an Online Sequential Extreme Learning Machine in detecting voice pathology using the Malaysian Voice Pathology Database. 在线序列极限学习机使用马来西亚语音病理学数据库检测语音病理学的准确性。
IF 3.4 3区 医学 Q1 OTORHINOLARYNGOLOGY Pub Date : 2023-09-20 DOI: 10.1186/s40463-023-00661-6
Nur Ain Nabila Za'im, Fahad Taha Al-Dhief, Mawaddah Azman, Majid Razaq Mohamed Alsemawi, Nurul Mu Azzah Abdul Latiff, Marina Mat Baki

Background: A multidimensional voice quality assessment is recommended for all patients with dysphonia, which requires a patient visit to the otolaryngology clinic. The aim of this study was to determine the accuracy of an online artificial intelligence classifier, the Online Sequential Extreme Learning Machine (OSELM), in detecting voice pathology. In this study, a Malaysian Voice Pathology Database (MVPD), which is the first Malaysian voice database, was created and tested.

Methods: The study included 382 participants (252 normal voices and 130 dysphonic voices) in the proposed database MVPD. Complete data were obtained for both groups, including voice samples, laryngostroboscopy videos, and acoustic analysis. The diagnoses of patients with dysphonia were obtained. Each voice sample was anonymized using a code that was specific to each individual and stored in the MVPD. These voice samples were used to train and test the proposed OSELM algorithm. The performance of OSELM was evaluated and compared with other classifiers in terms of the accuracy, sensitivity, and specificity of detecting and differentiating dysphonic voices.

Results: The accuracy, sensitivity, and specificity of OSELM in detecting normal and dysphonic voices were 90%, 98%, and 73%, respectively. The classifier differentiated between structural and non-structural vocal fold pathology with accuracy, sensitivity, and specificity of 84%, 89%, and 88%, respectively, while it differentiated between malignant and benign lesions with an accuracy, sensitivity, and specificity of 92%, 100%, and 58%, respectively. Compared to other classifiers, OSELM showed superior accuracy and sensitivity in detecting dysphonic voices, differentiating structural versus non-structural vocal fold pathology, and between malignant and benign voice pathology.

Conclusion: The OSELM algorithm exhibited the highest accuracy and sensitivity compared to other classifiers in detecting voice pathology, classifying between malignant and benign lesions, and differentiating between structural and non-structural vocal pathology. Hence, it is a promising artificial intelligence that supports an online application to be used as a screening tool to encourage people to seek medical consultation early for a definitive diagnosis of voice pathology.

背景:建议对所有发音困难的患者进行多维语音质量评估,这需要患者去耳鼻喉科诊所就诊。本研究的目的是确定在线人工智能分类器——在线序列极限学习机(OSELM)在检测语音病理学方面的准确性。在本研究中,创建并测试了马来西亚语音病理学数据库(MVPD),这是第一个马来西亚语音数据库。方法:该研究包括382名参与者(252名正常语音和130名发音困难语音),纳入拟议的MVPD数据库。获得了两组的完整数据,包括语音样本、喉镜视频和声学分析。获得了发音困难患者的诊断。每个语音样本都使用特定于每个个体的代码进行匿名化,并存储在MVPD中。这些语音样本被用于训练和测试所提出的OSELM算法。评估了OSELM的性能,并将其与其他分类器在检测和区分发音困难的准确性、敏感性和特异性方面进行了比较。结果:OSELM检测正常和发音困难的准确率、灵敏度和特异性分别为90%、98%和73%。该分类器区分结构性和非结构性声带病变,准确率、灵敏度和特异性分别为84%、89%和88%,而区分恶性和良性病变,准确度、灵敏度和特异度分别为92%、100%和58%。与其他分类器相比,OSELM在检测发音困难、区分结构性与非结构性声带病理以及恶性与良性声带病理方面表现出优越的准确性和敏感性。结论:与其他分类器相比,OSELM算法在检测语音病理、区分恶性和良性病变以及区分结构和非结构语音病理方面表现出最高的准确性和灵敏度。因此,它是一种很有前途的人工智能,支持将在线应用程序用作筛查工具,鼓励人们尽早寻求医疗咨询,以最终诊断语音病理。
{"title":"The accuracy of an Online Sequential Extreme Learning Machine in detecting voice pathology using the Malaysian Voice Pathology Database.","authors":"Nur Ain Nabila Za'im, Fahad Taha Al-Dhief, Mawaddah Azman, Majid Razaq Mohamed Alsemawi, Nurul Mu Azzah Abdul Latiff, Marina Mat Baki","doi":"10.1186/s40463-023-00661-6","DOIUrl":"10.1186/s40463-023-00661-6","url":null,"abstract":"<p><strong>Background: </strong>A multidimensional voice quality assessment is recommended for all patients with dysphonia, which requires a patient visit to the otolaryngology clinic. The aim of this study was to determine the accuracy of an online artificial intelligence classifier, the Online Sequential Extreme Learning Machine (OSELM), in detecting voice pathology. In this study, a Malaysian Voice Pathology Database (MVPD), which is the first Malaysian voice database, was created and tested.</p><p><strong>Methods: </strong>The study included 382 participants (252 normal voices and 130 dysphonic voices) in the proposed database MVPD. Complete data were obtained for both groups, including voice samples, laryngostroboscopy videos, and acoustic analysis. The diagnoses of patients with dysphonia were obtained. Each voice sample was anonymized using a code that was specific to each individual and stored in the MVPD. These voice samples were used to train and test the proposed OSELM algorithm. The performance of OSELM was evaluated and compared with other classifiers in terms of the accuracy, sensitivity, and specificity of detecting and differentiating dysphonic voices.</p><p><strong>Results: </strong>The accuracy, sensitivity, and specificity of OSELM in detecting normal and dysphonic voices were 90%, 98%, and 73%, respectively. The classifier differentiated between structural and non-structural vocal fold pathology with accuracy, sensitivity, and specificity of 84%, 89%, and 88%, respectively, while it differentiated between malignant and benign lesions with an accuracy, sensitivity, and specificity of 92%, 100%, and 58%, respectively. Compared to other classifiers, OSELM showed superior accuracy and sensitivity in detecting dysphonic voices, differentiating structural versus non-structural vocal fold pathology, and between malignant and benign voice pathology.</p><p><strong>Conclusion: </strong>The OSELM algorithm exhibited the highest accuracy and sensitivity compared to other classifiers in detecting voice pathology, classifying between malignant and benign lesions, and differentiating between structural and non-structural vocal pathology. Hence, it is a promising artificial intelligence that supports an online application to be used as a screening tool to encourage people to seek medical consultation early for a definitive diagnosis of voice pathology.</p>","PeriodicalId":16615,"journal":{"name":"Journal of Otolaryngology - Head & Neck Surgery","volume":"52 1","pages":"62"},"PeriodicalIF":3.4,"publicationDate":"2023-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512596/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41147624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the Editor of Journal of Otolaryngology regarding "Risk of diabetes in patients with sleep apnea: comparison of surgery versus CPAP in a long-term follow-up study". 致《耳鼻喉科杂志》编辑的关于“睡眠呼吸暂停患者患糖尿病的风险:长期随访研究中手术与CPAP的比较”的信。
IF 3.4 3区 医学 Q1 OTORHINOLARYNGOLOGY Pub Date : 2023-09-19 DOI: 10.1186/s40463-023-00662-5
Nguyen Truong, Bao Sciscent, F Jeffrey Lorenz, David Goldrich, Neerav Goyal

Obstructive sleep apnea (OSA) is associated with multiple chronic comorbidities with treatments including continuous positive airway pressure (CPAP), upper airway surgery (UAS), and hypoglossal nerve stimulation (HNS). Given the complexity of the condition and multiple treatment options, there is an ongoing debate to determine the best management. O'Connor-Reina et al. recently published a paper titled "Risk of diabetes in patients with sleep apnea: comparison of surgery versus CPAP in a long-term follow-up study." In their study, the authors stated that OSA patients who received surgery had a 50% less chance of developing diabetes compared to patients who only received CPAP treatment. However, we would like to point out some limitations that warrant attention and caution interpretation of the findings by physicians and patients.

阻塞性睡眠呼吸暂停(OSA)与多种慢性合并症有关,治疗包括持续气道正压通气(CPAP)、上呼吸道手术(UAS)和舌下神经刺激(HNS)。考虑到病情的复杂性和多种治疗方案,目前仍在争论如何确定最佳治疗方案。O’Connor-Reina等人最近发表了一篇题为《睡眠呼吸暂停患者患糖尿病的风险:长期随访研究中手术与CPAP的比较》的论文。在他们的研究中,作者指出,与只接受CPAP治疗的患者相比,接受手术的OSA患者患上糖尿病的几率降低了50%。然而,我们想指出一些局限性,值得医生和患者注意并谨慎解释这些发现。
{"title":"Letter to the Editor of Journal of Otolaryngology regarding \"Risk of diabetes in patients with sleep apnea: comparison of surgery versus CPAP in a long-term follow-up study\".","authors":"Nguyen Truong, Bao Sciscent, F Jeffrey Lorenz, David Goldrich, Neerav Goyal","doi":"10.1186/s40463-023-00662-5","DOIUrl":"10.1186/s40463-023-00662-5","url":null,"abstract":"<p><p>Obstructive sleep apnea (OSA) is associated with multiple chronic comorbidities with treatments including continuous positive airway pressure (CPAP), upper airway surgery (UAS), and hypoglossal nerve stimulation (HNS). Given the complexity of the condition and multiple treatment options, there is an ongoing debate to determine the best management. O'Connor-Reina et al. recently published a paper titled \"Risk of diabetes in patients with sleep apnea: comparison of surgery versus CPAP in a long-term follow-up study.\" In their study, the authors stated that OSA patients who received surgery had a 50% less chance of developing diabetes compared to patients who only received CPAP treatment. However, we would like to point out some limitations that warrant attention and caution interpretation of the findings by physicians and patients.</p>","PeriodicalId":16615,"journal":{"name":"Journal of Otolaryngology - Head & Neck Surgery","volume":"52 1","pages":"61"},"PeriodicalIF":3.4,"publicationDate":"2023-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510124/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41159050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Image guidance system use amongst Canadian otolaryngologists: a nationwide survey 图像引导系统在加拿大耳鼻喉科医生中的使用:一项全国性调查
IF 3.4 3区 医学 Q1 OTORHINOLARYNGOLOGY Pub Date : 2022-06-13 DOI: 10.1186/s40463-022-00581-x
T. McHugh, D. Sommer, A. M. ThambooTewfik, K. Smith, T. McHugh
{"title":"Image guidance system use amongst Canadian otolaryngologists: a nationwide survey","authors":"T. McHugh, D. Sommer, A. M. ThambooTewfik, K. Smith, T. McHugh","doi":"10.1186/s40463-022-00581-x","DOIUrl":"https://doi.org/10.1186/s40463-022-00581-x","url":null,"abstract":"","PeriodicalId":16615,"journal":{"name":"Journal of Otolaryngology - Head & Neck Surgery","volume":"57 1","pages":""},"PeriodicalIF":3.4,"publicationDate":"2022-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77897326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Total thyroidectomy versus hemithyroidectomy with intraoperative radiofrequency ablation for unilateral thyroid cancer with contralateral nodules: A propensity score matching study 全甲状腺切除术与半甲状腺切除术联合术中射频消融治疗单侧甲状腺癌伴对侧结节:倾向评分匹配研究
IF 3.4 3区 医学 Q1 OTORHINOLARYNGOLOGY Pub Date : 2022-06-11 DOI: 10.1186/s40463-022-00578-6
Q. Yuan, Lewei Zheng, J. Hou, R. Zhou, Gaoran Xu, Chengxin Li, Gaosong Wu
{"title":"Total thyroidectomy versus hemithyroidectomy with intraoperative radiofrequency ablation for unilateral thyroid cancer with contralateral nodules: A propensity score matching study","authors":"Q. Yuan, Lewei Zheng, J. Hou, R. Zhou, Gaoran Xu, Chengxin Li, Gaosong Wu","doi":"10.1186/s40463-022-00578-6","DOIUrl":"https://doi.org/10.1186/s40463-022-00578-6","url":null,"abstract":"","PeriodicalId":16615,"journal":{"name":"Journal of Otolaryngology - Head & Neck Surgery","volume":"46 4 1","pages":""},"PeriodicalIF":3.4,"publicationDate":"2022-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83181702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Journal of Otolaryngology - Head & Neck Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1